The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical and pharmacodynamic (PD) results of a phase I trial with AMP-224 (B7-DC Fc) that binds to the PD-1 receptor.
Jeffrey R. Infante
No relevant relationships to disclose
John D. Powderly
Employment or Leadership Position - Biolytics Pharma
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Genentech/Roche
Stock Ownership - Biolytics Pharma
Honoraria - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Amgen; Amplimmune; Celldex; Genentech/Roche; ImClone Systems; Lilly; Millennium
Other Remuneration - Biolytics Pharma
Howard A. Burris
No relevant relationships to disclose
Muaiad Kittaneh
No relevant relationships to disclose
Jessica Houston Grice
No relevant relationships to disclose
James F Smothers
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Other Remuneration - Amplimmune
Sara Brett
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Other Remuneration - Amplimmune
Margaret E. Fleming
Employment or Leadership Position - Amplimmune
Stock Ownership - Amplimmune
Rena May
Employment or Leadership Position - Amplimmune
Stock Ownership - Amplimmune
Shannon Marshall
Employment or Leadership Position - Amplimmune
Stock Ownership - Amplimmune
Martin Devenport
Employment or Leadership Position - Amplimmune
Stock Ownership - Amplimmune
Stanley Pillemer
Consultant or Advisory Role - Amplimmune
Stock Ownership - Amplimmune
Drew M. Pardoll
Consultant or Advisory Role - Amplimmune (U)
Lieping Chen
Consultant or Advisory Role - Amplimmune
Stock Ownership - Amplimmune
Research Funding - Amplimmune
Solomon Langermann
Employment or Leadership Position - Amplimmune
Stock Ownership - Amplimmune
Patricia LoRusso
Research Funding - Amplimmune